In re Omega Healthcare Inv’rs, Inc. Sec. Litig.
No. 19-1095
UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT
August 3, 2020
August Term 2019 (Argued: November 13, 2019 | Decided: August 3, 2020)
Before: LEVAL, WESLEY, and LIVINGSTON, Circuit Judges.
Plaintiffs-Appellants brought this putative class action against Omega Healthcare Investors, Inc., a publicly traded real estate investment trust that invests in healthcare facilities, and against Omega’s chief executives, asserting claims under Section 10(b) and 20(a) of the Securities Exchange Act of 1934,
Because we find that the complaint adequately alleges that Omega acted with the requisite scienter in failing to disclose the loan, we REVERSE and REMAND for proceedings consistent with this opinion.
JACOB A. GOLDBERG, (David Dean, on the brief) The Rosen Law Firm, P.A., Jenkintown, PA, for Plaintiffs-Appellants.
ERIC RIEDER, (Heather S. Goldman, on the brief), Bryan Cave Leighton Paisner, LLP, New York, NY, for Defendants-Appellees.
Plaintiffs-Appellants, Royce Setzer, Earl Holtzman, Dror Gronich, and Steven Klein, brought this putative class action against Omega Healthcare Investors, Inc., a publicly traded Maryland corporation that invests in healthcare facilities, and against Omega’s chief executives. Plaintiffs assert claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”),
Because we find that the complaint adequately alleges that Omega acted with scienter in failing to disclose the loan, we reverse the district court’s decision and remand for proceedings consistent with this opinion.
BACKGROUND
I. Facts1
Omega is a self-administered real estate investment trust that invests in healthcare facilities, such as skilled nursing and assisted living facilities. Omega either owns the properties and leases them to the facility operators, or it provides operators with mortgage financing. Omega reports its financial performance to the market through its Funds from Operations (“FFO”) and Adjusted Funds from Operations (“AFFO”) metrics. Thus, Omega’s
At all relevant times, Defendant C. Taylor Pickett served as Omega’s chief executive officer; Defendant Robert O. Stephenson served as the chief financial officer; and Defendant Daniel J. Booth served as the chief operating officer (together, with Omega, “Defendants”).
By late 2016 and early 2017, Omega’s second largest operator, Orianna,3 began experiencing severe financial difficulties and became delinquent on its rent. Orianna operated 59 skilled nursing facilities across the country, representing seven percent of Omega’s investment portfolio at that time (roughly $619 million in gross investment). In response to Orianna’s financial troubles, on May 2, 2017, Omega provided a $15 million working capital loan to the company (the “Loan”).4
A. First Quarter: January 1, 2017 through March 31, 2017
Two days after it made the Loan, Omega held a conference call with analysts to discuss its results for the first quarter of 2017. On the call, Defendant Booth described Orianna’s “performance pressure,” which he claimed was
“exacerbated” by “complete replacement of senior management” in 2016. J.A. 25 ¶ 35. Booth indicated that “[t]he new management team well known and respected by Omega worked throughout 2016 to transform the culture of the company, which included changing out many facility-level management teams.” Id. Booth acknowledged that during this “transition period” Orianna’s operational performance dipped below 1x EBITDAR5 coverage for 2016. Id. However, in an effort to help Orianna during the transition period, Omega had “embarked on an effort to sell off [Orianna’s] northwest region, which consisted of 7 facilities,” and that “3 facilities [had] already been sold.” Id. at 25–26 ¶ 35. Defendant Pickett added that Orianna was rebranding, moving its corporate headquarters, and making significant business changes in an attempt to recover.6
lease. The sale of these facilities is expected to close in the second quarter of 2017.
J.A. 327. The 10-Q also stated that there had been “no material changes to [Omega’s] risk factors as previously disclosed . . . in Part 1 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016,” and incorporated by reference the risk disclosures in that document. Id. at 36 ¶ 51. Notably, the “risk factors” disclosure in Omega’s 2016 10-K stated that the company was “exposed to the risk that a
Defendants Stephenson and Pickett also stated that Orianna was 45 days past due on its rent payments.7 An analyst asked why Omega’s 2017 adjusted FFO guidance, which had been estimated at $3.40 to $3.44 per diluted share, did not reflect that Orianna was no longer paying rent. Id. at 31 ¶ 44. Defendant Pickett responded that “at 45 days past due, to start fiddling around with guidance, just doesn’t make any sense,” and reassured the analyst that Omega “feel[s] pretty comfortable that [Orianna is] going to come back with coverages at [its] previous
level.” Id. Omega did not mention the Loan in the conference call or in any of its first quarter filings.
B. Second Quarter: April 1, 2017 through June 30, 2017
Orianna continued to experience problems during the second quarter of 2017. Nevertheless, on July 26, 2017, Omega issued a press release revising Omega’s guidance on FFO upwards to between $3.42 and $3.44 “per diluted share.” J.A. 40 ¶ 59.
Prior to Omega’s July 27, 2017 second quarter conference call, analysts following Omega raised concerns regarding Orianna’s ability to pay rent. One analyst issued a report focusing on Orianna’s rent delinquency, indicating that he was “look[ing] to hear more about what [rent] payments (if any) were recouped from [Orianna] after [the first quarter] shortfall.” J.A. 37–38 ¶ 54. Another analyst report emphasized that “[t]enant health remains an issue for [Omega’s] portfolio” such that two tenants “are now more than 30-days late on their rental payments . . . highlight[ing] potential material risks to the near-term income stream.” Id. at 38–39 ¶ 55. Plaintiffs allege that one of the two tenants referred to in this report is Orianna. Id. at 39 ¶ 56.
During Omega’s conference call, Booth reported that while Omega was “optimistic” that coverages had stabilized, Omega “continue[d] to see certain regional operators struggle with various operational pressures,” including Orianna. Id. at 41–42 ¶ 61.
Booth then explained that while Omega was “consciously [sic] optimistic that the combination of . . . [Orianna’s] efforts will result in steadily improving margins and eventually return to its former profitability,” the “past due rent has reached nearly ninety days in arrears.” Id. He suggested that “any further deterioration and/or failure of [Orianna] to achieve its budgeted plan may result in cash basis accounting and a potential review of the value of these capital lease assets.”8 Id. at 42 ¶ 61. Booth
Omega’s 10-Q for the second quarter made similar statements, including that Orianna “has been facing liquidity pressures following a management transition, but has been showing signs of operational improvement and is currently making partial monthly rent payments.” Id. at 43 ¶ 64 (emphasis added). The Complaint alleges that this statement and the statements made by Booth during the July 27, 2017 conference call were “false and misleading” because those statements implied that Orianna had been making rent payments from its own operating income, when at least part of those rent payments was funded by the undisclosed loan Omega had extended to Orianna several months earlier. Id. at 26 ¶ 36, 42–44 ¶¶ 62, 64, 65. Plaintiffs assert that Omega’s repeated failure to disclose the existence of the Loan was part of a “surreptitious[]” scheme “to avoid disclosing to the market both the gravity of Orianna’s financial woes and the likely impact on Omega’s financial results.” Id. at 28 ¶ 39.
The 10-Q also explained that “[t]he current management of [Orianna] is pursuing operational improvements,” including “replacing executive management and senior level management, renegotiating vendor contracts and establishing a centralized referral network.” Id. at 43–44 ¶ 64. Moreover, Omega “expect[ed] to sell two other facilities and transition its existing Texas portfolio to
another operator during the third quarter of 2017” and was “optimistic that the combination of these efforts will result in improving margins and performance by this operator.” Id. at 44 ¶ 64. The 10-Q specifically noted, however, that while Omega “is currently recording rental revenue from this provider on an accrual basis,” it will “continue[] to monitor [Orianna’s] operating plan and in the event its performance deteriorates, [it] will reassess the carrying value of the portfolio and consider recording future rental revenue on a cash basis.” Id. Omega did not disclose the Loan during the second quarter.
Following these statements, another analyst emphasized the general concern over Orianna’s ability to pay rent. Id. at 45 ¶ 66 (“[I]nvestors were more concerned with the health of two [of Omega’s] top ten tenants [including Orianna] . . . who continue to not be current on their rents.”).
C. Third Quarter: July 1, 2017 through October 31, 2017
By the end of the third quarter, Orianna had not achieved its recovery goals. Omega placed Orianna on a cash basis, recognizing no revenue for Orianna for the quarter. On October 30, 2017, Omega issued a press release, disclosing impairments of $194.7 million on direct financing leases and $9.5 million in provisions for uncollectible accounts related to Orianna, contributing to an overall
$46.8 million loss of FFO. J.A. 46–48, 613–17. Omega described the financial losses as follows:
During our second quarter earnings call, we stated we were closely monitoring one of our operators and may have to place them on a cash basis for revenue recognition if their performance did not improve. Since Orianna did not achieve
their revised operating plan and pay their full contractual rent, we placed them on a cash basis and therefore our third quarter results, including AFFO [“Adjusted Funds From Operation”] and FAD [“Funds Available For Distribution”], do not include any revenue related to Orianna . . . . Since 93% of our Orianna portfolio was classified as a direct financing lease, placing them on a cash basis and initiating the process to transition some or all of their portfolio to new operators also required us to record several large provisions related to the direct financing leases during the quarter . . . . We are lowering our 2017 guidance to reflect the temporary loss of third and fourth quarter 2017 revenue primarily related to placing Orianna . . . on a cash basis.
Id. at 48 (emphasis added).
The next day, Omega held a conference call to discuss its third quarter results. On the call, Defendant Pickett, Omega’s CEO acknowledged “[t]he reduction in adjusted FFO . . . is primarily related to converting the Orianna portfolio to cash basis accounting.” Id. at 49 ¶ 69. Similarly, Defendant Stephenson indicated, “[w]e have lowered our 2017 adjusted FFO guidance to $3.27 to $3.28 per share. The reduction . . . reflects the temporary loss of Orianna revenue for both the third and fourth quarters.” Id. at 50. Defendant Booth added
that while Omega “ha[s] endeavored to assist Orianna in streamlining operations by transitioning both their Northwest and Texas regions, the overall portfolio continues to struggle in past due rent headwind” and “has fallen significantly behind on rent.” Id. Following the conference call, Omega’s stock fell 6.8 percent.
On November 7, 2017, Omega filed its 10-Q for the third quarter, which noted that it had restructured two of Orianna’s direct financing leases, resulting in impairments totaling $20.8 million, that “Orianna ha[d] not satisfied the contractual payments due under the terms of the remaining two direct financing leases or the separate operating lease with [Omega] and the collectability of future amounts due is uncertain,” and that Omega was “in preliminary discussions with Orianna regarding future actions.” Id. at 52 ¶ 71.
In March 2018, Orianna filed for bankruptcy. Id. at 22 ¶ 29.
II. Litigation History
Following numerous procedural matters not relevant here,9 Plaintiffs filed their Consolidated Amended Class Action Complaint (the “Complaint”) on behalf
of themselves and all persons who purchased or otherwise acquired Omega’s securities during the Class Period. Several months thereafter, Defendants filed a motion to dismiss the Complaint.
The district court granted Defendants’ motion, determining that although “plaintiffs ha[d] sufficiently alleged materiality with respect to the omission of the [Loan,]” the “failure to plead a strong inference of scienter [was] fatal” to their claim. SPA-18.10 The district court found that Plaintiffs failed to allege that Omega acted recklessly because the Complaint failed to allege any GAAP violation and because Omega had “disclosed Orianna’s
The district court entered judgment and this appeal followed.
DISCUSSION
Under Section 10(b) of the Exchange Act, it is unlawful to “use or employ, in connection with the purchase or sale of any security . . . any manipulative or
deceptive device or contrivance in contravention of [the] rules and regulations” that the SEC prescribes.
(a) To employ any device, scheme, or artifice to defraud,
(b) To make any untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading, or
(c) To engage in any act, practice, or course of business which operates or would operate as a fraud or deceit upon any person, in connection with the purchase or sale of any security.
To state a claim under Section 10(b) and
particularity.”
The principal issue before us is whether the district court erred in finding that the Complaint failed to adequately plead scienter. To adequately plead scienter under the
I. Plaintiffs Adequately Allege Defendants’ Duty to Disclose the Loan
Plaintiffs’ theory of scienter is
standards of ordinary care to the extent that the danger was either known to the defendant or so obvious that the defendant must have been aware of it”).12
Plaintiffs argue that Defendants were duty-bound to disclose the Loan because the failure to do so rendered statements about Orianna’s performance actionably misleading. See Appellants’ Br. 29–31, 41–51; Appellants’ Reply Br. 13–16. We agree.
Omega’s duty to disclose the Loan arose directly from
On May 4, 2017, Defendants told analysts and investors that, as of March 31, 2017, Orianna was “45 days past due” on its rental payments. J.A. 301. Defendants later indicated that, as of June 30, 2017, Orianna was “approximately 90 days past due on rent payments,” but that it was “currently making partial monthly rent payments.” Id. at 590. By failing to disclose that the Loan accounted for all (or most) of Orianna’s “partial monthly rent payments,”13 Defendants effectively
communicated that, notwithstanding any disclosures regarding Orianna’s performance issues, Orianna could pay more than half of its rent from its earnings.14 The omission concealed the extent of Orianna’s solvency problems: Orianna could not pay rent without borrowing from its landlord. Under the facts as alleged, because in July 2017 Omega had stated that Orianna was making “partial monthly payments,” Omega was duty-bound to disclose that its loan was the source of Orianna’s rent payments.15
Moreover, the Complaint alleges that the primary purpose of the Loan was to enable “Orianna to cover real estate taxes and to pay rent back to Omega.” Id. at 44. The strong inference is that Orianna could not have made its “partial monthly rent payments” but for the Loan.
II. Plaintiffs Adequately Allege Facts Showing Omega’s Recklessness
Although the existence of a clear duty to disclose the omitted information is necessary to state a claim under a recklessness theory of scienter, a plaintiff must also allege facts showing the defendant’s “conscious recklessness—i.e., a state of mind approximating actual intent, and
The question is: Was Omega’s decision not to disclose the Loan—in the context of
accurate and complete.” (citations omitted)). We do not understand these references to the “whole truth” and to speaking “completely” to describe a duty to disclose all the facts that pertain to a subject (many of which would be immaterial), but instead to describe a duty not to omit material facts whose omission, in the light of what was stated, would be misleading. See
its disclosures regarding Orianna’s financial health—a sufficiently extreme departure from the standards of ordinary care to satisfy the PSLRA’s requirement for showing recklessness?
It was. We have previously explained that “securities fraud claims typically have sufficed to state a claim based on recklessness when they have specifically alleged defendants’ knowledge of facts or access to information contradicting their public statements.” Novak, 216 F.3d at 308. Thus, in determining whether the Complaint adequately alleges facts giving rise to a strong inference that Defendants acted recklessly, we focus on Defendants’ degree of knowledge and the seriousness of the impact that results from their conduct. See id. (discussing various examples of recklessness sufficient for Section 10(b) liability).
Here, the allegations in the Complaint raise a strong inference that Defendants acted, at the very least, recklessly in choosing to disclose incomplete and misleading information regarding Orianna. As the district court noted, there is no question that the inability of one of Omega’s “top” tenants to pay rent absent the Loan was material. See SPA-18. Orianna represented seven percent of Omega’s investment portfolio; it was a significant source of income through rental payments. See J.A. 21 ¶ 28; see also id. at 523 (explaining that Orianna’s rent
obligations to Omega amounted to $44 million per year, or roughly $11 million per quarter). Orianna’s performance plainly impacted Omega’s overall financial health; Omega had to know that revealing the full extent of Orianna’s performance problems would have been troubling news to its investors.
Moreover, assuming most of the Loan proceeds were used to pay Orianna’s rent during the second quarter—as the Complaint alleges, see id. at 26 ¶ 36, 31–33 ¶¶ 45, 47—Omega knew that its money would be going directly back into its FFO and/or AFFO. Nevertheless, Defendants chose to represent these numbers as “partial monthly payments” indicating that Orianna was on the road to recovery.16 The facts as alleged create a compelling inference that Defendants made a conscious decision to not disclose the Loan in order to understate the extent of Orianna’s financial difficulties. This is especially convincing where multiple
analysts homed in on Orianna’s rental payments being key to Omega’s prospects. See id. at 37–39, ¶¶ 54–55
That Defendants made several disclosures regarding Orianna’s financial difficulties does not alter our conclusion. Indeed, those disclosures support a finding of recklessness here as they strongly suggest that Defendants sought to use Orianna’s “partial rental payments” to express optimism and underrepresent the extent of those very problems.
The facts alleged in the Complaint therefore support a strong inference that Defendants’ failure to disclose the Loan constituted “conscious misbehavior,” Kalnit, 264 F.3d at 144, or, at the very least, “highly unreasonable [conduct] . . . [that] represents an extreme departure from the standards of ordinary care.” Hennessee, 573 F.3d at 109. The inference is “at least as compelling as any opposing inference one could draw from the facts alleged.” Tellabs, 551 U.S. at 314. Reversal of the district court’s decision is therefore in order.
III. Plaintiffs’ Section 20(a) Claims
Finally, Plaintiffs also allege control person liability under Section 20(a) of the Exchange Act. See
CONCLUSION
For the reasons stated above, we REVERSE the judgment of the district court and REMAND for further proceedings consistent with this opinion.
Notes
J.A. 138.NAREIT [National Association of Real Estate Investment Trusts] FFO is a non-GAAP financial measure. We use NAREIT FFO as one of several criteria to measure the operating performance of our business. We further believe that by excluding the effect of depreciation, amortization, impairment on real estate assets and gains or losses from sales of real estate, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, NAREIT FFO can facilitate comparisons of operating performance between periods and between other REITs.
In March 2017, we executed sale agreements with two unrelated third parties to sell the 7 Northwest facilities with a carrying value of approximately $36.4 million for $34.0 million. As a result, we recorded an allowance for loss of approximately $2.4 million. For the three months ended March 31, 2017, we recognized approximately $0.8 million of direct financing lease income on a cash basis related to the Northwest facilities
